Main Article Content
Carbapenem-resistant Gram negative bacteria in healthcare setting is an important medical problem and a major threat. These Gram negative bacteria are rapidly spreading worldwide. Clinical bacteria isolates were obtained from clinical samples Urine, High Vaginal Swab (HVS), Wound Swab (WS), Stools, Ear Swab (ES), Endocervical Swab (ECS), Sputum and Blood, from two tertiary hospitals. Environmental samples were also collected from both hospitals using standard sampling techniques. Multiple drug resistant (MDR) patterns were determined using disc diffusion technique. Biochemical tests were used in the identification. Antibiotics sensitivity of clinical and environmental isolates was verified using disc diffusion method. Detection of carbapenemase producing bacteria was done using double disc synergy test and modified Hodge test. Data obtained were analysed using descriptive statistics. Clinical bacteria (403) obtained were distributed 271 Federal Medical Centre(FMC) and 132 Benue State University Teaching Hospital (BSUTH) out of which 299 were confirmed Gram negative, 218 (FMC) and 81 (BSUTH), respectively. Thirty-nine Gram negative bacteria were also isolated from the environmental samples. A higher percentage of carbapenemase producers (12.8%) were found in environmental isolates compared to 2.7% in clinical isolates. Any levels of resistance to carbapenems calls for the need to reduce the indiscriminate use of this group of antibiotics and monitoring both in the hospitals and environment.
Centers for disease control and prevention. Office of Infectious Disease Antibiotic resistance threats in the United States; 2013.
(Accessed January 28, 2015)
Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Frontiers in Microbiology. 2013;4:47.
Lushniak BD. Antibiotic resistance: A public health crisis. Public Health Report. 2014;129(4):314–316.
Rossolini GM, Arena F, Pecile P, Pollini S. Update on the antibiotic resistance crisis. Current Opinion in Pharmacology. 2014; 18:56–60.
Hsu RB, Chu SH. Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus. American Journal of Medical Science. 2004;328(3):150-155.
Stone SP, Teare L, Cookson BD. The evidence for hand hygiene. Lancet. 2001; 357:479-480.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multi drug resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology Infection. 2012;18:268–281.
Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre JA. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Science Translational Medicine. 2012;4:148-116.
Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: Past, present and future. Antimicrobial Agents Chemotherapy. 2011;55:4943–60.
Miriagou V, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P. Acquired carbapenemases in Gram-negative bacterial pathogens: Detection and surveillance issues. Clinical Microbiology Infection. 2010;16(2):112-122.
Amjad AMI, Abbasi SA, Farwa U, Malik N, Zia F. Modifed Hodge test: A simple and effective test for detection of carbapenemase production. Iranian Journal of Microbiology. 2011;3(4):189-193.
Asthana S, Mathur P, Tak V. Detection of carbapenemase production inGram-negative bacteria. Journal of Laboratory Physicians. 2014;6(2):69.
Okoche D, Benon B, Asiimwe, Fred AK, Laban K, Christine FN. Prevalence and characterization of carbapenem-resistant enterobacteriaceae isolated from Mulago National Referral Hospital, Uganda Public Library of Science. PLOS ONE. 2015; 10(8):135745.
Van der Zwaluw KHA, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. The carbapenem inactivation method (CIM), a simple and low-cost alternative forthe Carba NP test to assess phenotypic carbapenemase activity in Gram negativerods. PLoS One. 2015; 10(e0123690).
Pierce VM, et al. The modified carbapenem inactivation method (mCIM) for phenotypic detection of carba-penemase production among Entero-bacteriaceae. Journal of Clinical Micro-biology. 2017;193-217.
Virginia M, Pierce PJS, David R, Lonsway, Darcie E, Roe-Carpenter DJ, Kristie Johnson, William B, Brasso, April M. Bobenchik, Zabrina C, Lockett A, Charnot-Katsikas, Mary Jane Ferraro, Richard B, Thomson Jr., Stephen G, Jenkins, Brandi M, Limbago, Sanchita Das. The modified carbapenem inactivation method (mCIM) for phenotypic detection of carbapenemase production among enterobacteriaceae. Journal of Clinical Microbiology. 2017;26:565–572.
Pasteran F, et al. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class A carbapenemase in species of Enterobacteriaceae by incorporating boronic acid. Journal of Clinical Microbiology. 2010;48(4):1323-1332.
Hrabák J, Chudáčková E, Papagiannitsis C. Detection of carbapenemasesin E nterobacteriaceae: A challenge for diagnostic microbiological laboratories. Clinical Microbiology and Infection. 2014; 20(9):839-853.
Pasteran F, et al. Sensitive and specific modified hodge test for KPC and metallo-beta-lactamase detection in Pseudomonas aeruginosa by use of a novelindicator strain: Klebsiella pneumoniae ATCC 700603. Journal of Clinical Microbiology. JCM. 2011;05602-11.
Bialvaei AZ, et al. Current methods for the identification of carbapenemases. Journal of Chemotherapy. 2016;28(1):1-19.
Kirby WMM, Baurer AW, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single Disc method. American Journal of Clincal Pathology. 1966;45:493-496.
Wadi J, Haloub N, Al Ahmad M, Samara A, Romman A. Prevalence of meropenem susceptibility among Gram-negative pathogens isolated from intensive care units in Jordan. Internation Arabic Journal Antimicrobial Agents. 2011;1:1–8.
Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant enterobacteria-ceae in the United States. Expert Review Anti- Infective Therapy.2014;12:565– 80.
Zahedi Bialvaei A, SamadiKafil H, Ebrahimzadeh Leylabadlo H, Asgharzadeh M, Aghazadeh M. Dissemination of carbapenemases producing Gram negative bacteria in the Middle East. Iran Journal of Micro-biology. 2015;7:226–46.
Heudorf U, Büttner B, Hauri AM. Carbapenem-resistant Gram negative bacteria analysis of the data obtained through a mandatory reporting system in the Rhine-Mainregion, Germany, 2012-2015. GMS Hygiene and Infection Control; 2016.
Vanegas JM, Parra OL, Jiménez JN. Molecular epidemiology of carbapenem resistant Gram Negative Bacilli from infected pediatric population in tertiary-care hospitals in Medellín, Colombia: An increasing problem. BMC Infectious Diseases. 2016;16:463.
Karn S, Pant ND, Neupane S, Khatiwada S, Basnyat S, Shrestha B. Prevalence of carbapenem resistant bacterial strains isolated from different clinical samples: Study from atertiary care hospital in Kathmandu, Nepal. Journal of Biomedical Science. 2017;3:11–15.
Hawkey PM. The growing burden of antimicrobial Resistance. Journal of Antimicrobial Chemotherapy. 2008;62(1): 1-9.